NJ Jury Orders Roche To Pay $1.5M For Accutane User's IBD
A New Jersey jury on Tuesday awarded at retrial over $1.5 million to a woman who developed a form of inflammatory bowel disease after taking Hoffman-LaRoche Inc.'s acne drug Accutane, representing...To view the full article, register now.
Already a subscriber? Click here to view full article